Literature DB >> 33170418

Acute and chronic lithium treatment increases Wnt/β-catenin transcripts in cortical and hippocampal tissue at therapeutic concentrations in mice.

Vanessa J De-Paula1,2,3, Carla Cristine C Dos Santos4, Maria Carolina A Luque4,5, Taccyana M Ali4,5, Jorge E Kalil6,5,7, Orestes V Forlenza7, Edecio Cunha-Neto4,5,7.   

Abstract

Lithium activates Wnt/β-catenin signaling leading to stabilization of free cytosolic β-catenin. The aim of the present study is to evaluate the in vivo effect of acute and chronic lithium treatment on the expression of β-catenin target genes, addressing its transcripts HIG2, Bcl-xL, Cyclin D1, c-myc, in cortical and hippocampal tissue from adult mice. Lithium doses were established to yield therapeutic working concentrations. In acute treatment, mice received a 300µL of a 350 mg/kg solution of LiCl by gavage, and were euthanized after 2 h, 6 h and 12 h. To determine the effect of chronic treatment, animals were continuously fed either with chow supplemented with 2 g/kg Li2CO3, or regular chow (controls), being euthanized after 30 days. All animals had access to drinking water and 0.9% saline ad libitum. After acute and chronic treatments samples of peripheral blood were obtained from the tail vein for each animal, and serum concentrations of lithium were determined. All transcripts were up-regulated in cortical and hippocampal tissues of lithium-treated mice, both under acute and chronic treatments. There was a positive correlation between serum lithium concentrations and the increment in the expression of all transcripts. This effect was observed in all time points of the acute treatment (i.e., 2, 6 and 12 hours) and also after 30 days. We conclude that Wnt/β-catenin transcriptional response (HIG2, Bcl-xL, Cyclin D1 and c-myc) is up-regulated in the mouse brain in response to acute and chronic lithium treatment at therapeutic concentrations.

Entities:  

Keywords:  Bcl-xL; Cyclin D1; HIG2; Lithium; Wnt/β-catenin; c-myc

Year:  2020        PMID: 33170418     DOI: 10.1007/s11011-020-00638-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  12 in total

Review 1.  Validating GSK3 as an in vivo target of lithium action.

Authors:  W Timothy O'Brien; Peter S Klein
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

Review 2.  Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.

Authors:  Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Fei Liu; Cheng-Xin Gong; Inge Grundke-Iqbal
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

3.  Peroxisome proliferator-activated receptor gamma promotes neuroprotection by modulating cyclin D1 expression after focal cerebral ischemia.

Authors:  Lichun Pei; Yanqiao Zhang; Yina Zhang; Xiaojie Chu; Jingyuan Zhang; Ruitao Wang; Meiling Liu; Xiuying Zhu; Weigang Yu
Journal:  Can J Physiol Pharmacol       Date:  2010-07       Impact factor: 2.273

4.  Lithium chloride promotes neuronal differentiation of rat neural stem cells and enhances neural regeneration in Parkinson's disease model.

Authors:  Li Qi; Yonggang Tang; Wei He; Honghua Pan; Wenxian Jiang; Lin Wang; Weilin Deng
Journal:  Cytotechnology       Date:  2017-01-24       Impact factor: 2.058

5.  Bcl-xL Is Essential for the Survival and Function of Differentiated Neurons in the Cortex That Control Complex Behaviors.

Authors:  Ayumi Nakamura; Vijay Swahari; Charlotte Plestant; Ikuko Smith; Eric McCoy; Spencer Smith; Sheryl S Moy; E S Anton; Mohanish Deshmukh
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

6.  Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice.

Authors:  Giancarlo de Mattos Cardillo; Vanessa de Jesus Rodrigues De-Paula; Eliza Hiromi Ikenaga; Luciana Rodrigues Costa; Sergio Catanozi; Evelin Lisete Schaeffer; Wagner Farid Gattaz; Daniel Shikanai Kerr; Orestes Vicente Forlenza
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.

Authors:  Zachary Freyberg; Stephen J Ferrando; Jonathan A Javitch
Journal:  Am J Psychiatry       Date:  2009-11-16       Impact factor: 18.112

8.  Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammation.

Authors:  Jordane Malaterre; Cameron S McPherson; Delphine Denoyer; Emily Lai; Jim Hagekyriakou; Sally Lightowler; Koishi Shudo; Matthias Ernst; David M Ashley; Jennifer L Short; Greg Wheeler; Robert G Ramsay
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

9.  Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening.

Authors:  B Boyle; J K Morris; R McConkey; E Garne; M Loane; M C Addor; M Gatt; M Haeusler; A Latos-Bielenska; N Lelong; R McDonnell; C Mullaney; M O'Mahony; H Dolk
Journal:  BJOG       Date:  2014-02-04       Impact factor: 6.531

10.  GSK3β Regulates Brain Energy Metabolism.

Authors:  Stephen A Martin; Dylan C Souder; Karl N Miller; Josef P Clark; Abdul Kader Sagar; Kevin W Eliceiri; Luigi Puglielli; T Mark Beasley; Rozalyn M Anderson
Journal:  Cell Rep       Date:  2018-05-15       Impact factor: 9.423

View more
  1 in total

1.  Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges.

Authors:  V J De-Paula; O V Forlenza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-11-09       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.